HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Luciano J Costa Selected Research
Luciano J Costa Research Topics
Disease
66
Multiple Myeloma
04/2024 - 05/2009
12
Neoplasms (Cancer)
04/2024 - 09/2014
10
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 10/2008
8
Lymphoma (Lymphomas)
11/2021 - 09/2011
6
Residual Neoplasm
11/2023 - 01/2020
5
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2016 - 09/2013
4
Disease Progression
01/2024 - 12/2011
4
B-Cell Lymphoma (Lymphoma, B Cell)
10/2021 - 07/2008
4
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2017 - 02/2014
3
Chromosome Aberrations (Chromosome Abnormalities)
04/2024 - 12/2021
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 03/2016
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2018 - 12/2013
3
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 05/2009
3
Hodgkin Disease (Hodgkin's Disease)
10/2015 - 08/2010
2
Body Weight (Weight, Body)
12/2022 - 10/2008
2
Acute Promyelocytic Leukemia
01/2022 - 01/2021
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 03/2015
2
Second Primary Neoplasms (Neoplasms, Second)
01/2018 - 01/2015
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2015 - 07/2014
2
Leukemia
09/2014 - 12/2013
2
Renal Cell Carcinoma (Grawitz Tumor)
12/2007 - 03/2007
1
Infections
12/2023
1
Immunoglobulin Light-chain Amyloidosis
11/2023
1
Agammaglobulinemia (Hypogammaglobulinemia)
08/2023
1
Cytokine Release Syndrome
03/2023
1
Thrombosis (Thrombus)
11/2022
1
Anemia
04/2022
1
Autoimmune Hypothyroidism
01/2022
1
Frailty
01/2022
1
Carcinogenesis
12/2021
1
Pathologic Complete Response
01/2021
1
Paraproteinemias (Monoclonal Gammopathy)
01/2019
1
Bronchiolitis Obliterans Syndrome
11/2018
Drug/Important Bio-Agent (IBA)
16
Dexamethasone (Maxidex)
FDA Link
Generic
04/2024 - 11/2012
15
Lenalidomide (CC 5013)
FDA Link
04/2024 - 01/2015
13
daratumumab
IBA
04/2024 - 01/2019
10
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2023 - 08/2011
9
Bortezomib (Velcade)
FDA Link
04/2024 - 11/2012
8
Chimeric Antigen Receptors
IBA
12/2023 - 01/2019
7
Monoclonal Antibodies
IBA
01/2024 - 03/2015
6
Proteasome Inhibitors
IBA
01/2024 - 01/2018
5
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
04/2024 - 11/2021
5
carfilzomib
IBA
11/2023 - 04/2015
4
Biomarkers (Surrogate Marker)
IBA
11/2023 - 01/2020
4
Proteins (Proteins, Gene)
FDA Link
11/2023 - 10/2021
4
B-Cell Maturation Antigen
IBA
07/2023 - 01/2022
3
trans-crotonin (CTN)
IBA
10/2020 - 11/2018
3
selinexor
IBA
01/2020 - 01/2018
3
Rituximab (Mabthera)
FDA Link
01/2020 - 11/2014
3
Sirolimus (Rapamycin)
FDA Link
11/2018 - 03/2007
3
Busulfan (Busulfex)
FDA Link
01/2016 - 12/2013
2
idecabtagene vicleucel
IBA
04/2024 - 03/2023
2
Adenosine Monophosphate (AMP)
IBA
04/2024 - 01/2024
2
Immunomodulating Agents
IBA
03/2023 - 01/2022
2
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2022 - 01/2021
2
Arsenic Trioxide (Trisenox)
FDA Link
01/2022 - 01/2021
2
plerixafor
FDA Link
01/2019 - 12/2014
2
carboxyl radical (COO-)
IBA
01/2019 - 01/2019
2
Prednisone (Sone)
FDA Link
Generic
01/2019 - 11/2018
2
Melphalan (Alkeran)
FDA Link
Generic
01/2018 - 10/2008
2
Phosphatidylinositols (Phosphatidylinositol)
IBA
10/2016 - 03/2007
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
12/2014 - 02/2014
1
vinyltriethoxysilane (VTES)
IBA
11/2022
1
Immunoglobulin A (IgA)
IBA
04/2022
1
Immunoglobulin G (IgG)
IBA
04/2022
1
Immunoglobulin Isotypes
IBA
04/2022
1
Cyclin D1
IBA
01/2022
1
Blood Group Antigens (Blood Groups)
IBA
01/2022
1
PENTA
IBA
11/2021
1
Immunologic Factors (Immunomodulators)
IBA
11/2021
1
venetoclax
IBA
10/2021
1
Tyrosine Kinase Inhibitors
IBA
01/2021
1
isatuximab
IBA
01/2019
1
obinutuzumab
IBA
01/2019
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2019
1
Paraproteins
IBA
01/2019
1
Vincristine (Oncovin)
FDA Link
Generic
01/2019
1
fludarabine
IBA
11/2018
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2018
1
Calcineurin Inhibitors
IBA
11/2018
1
Cytarabine (Cytosar-U)
FDA Link
Generic
11/2018
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2018
1
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
01/2018
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
01/2018
Therapy/Procedure
50
Therapeutics
04/2024 - 12/2007
19
Cell Transplantation
01/2022 - 02/2013
9
Stem Cell Transplantation
01/2024 - 07/2008
9
Transplantation
10/2023 - 10/2008
7
Drug Therapy (Chemotherapy)
12/2021 - 01/2005
6
Hematopoietic Stem Cell Transplantation
01/2022 - 05/2009
4
Autologous Transplantation
02/2017 - 11/2013
3
Immunotherapy
04/2024 - 11/2014
3
Salvage Therapy
01/2021 - 08/2011
2
Withholding Treatment
11/2023 - 01/2022
2
Homologous Transplantation
03/2015 - 02/2013
1
Aftercare (After-Treatment)
11/2023
1
Duration of Therapy
11/2023
1
Hematopoietic Stem Cell Mobilization
01/2023
1
Blood Component Removal (Apheresis)
01/2019
1
Photopheresis
11/2018